On the upside
Texas Instruments (NYSE: TXN) raised its profit targets for the quarter as demand for its chip products stabilized.
An analyst upgraded Greif (NYSE: GEF), an industrial packaging products maker.
Shares of MDRNA (Nasdaq: MRNA) soared after the FDA approved its generic osteoporosis nasal spray.
On the downside
F.N.B. Corp. (NYSE: FNB) announced plans to sell $115 million in new stock to strengthen the bank's balance sheet.
An analyst downgraded chipmaker Jabil Circuit (NYSE: JBL).
Ceramics manufacturer Ceradyne (Nasdaq: CRDN) set lower guidance for 2009 due to reduced global demand for its products.
In the broad market, advancing issues outpaced decliners by a margin of 2 to 1 on the NYSE and by more than 2 to 1 on Nasdaq. The Russell 2000 which tracks small cap stocks gained 3 points to 528.
